“Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article”. Pak-Euro Journal of Medical and Life Sciences, vol. 9, no. 1, Mar. 2026, pp. 25-34, https://doi.org/10.31580/pjmls.v9i1.3417.